We serve Chemical Name:6-Bromo-3-iodoimidazo[1,2-a]pyrazine CAS:1245644-42-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-Bromo-3-iodoimidazo[1,2-a]pyrazine
CAS.NO:1245644-42-1
Synonyms:Imidazo[1,2-a]pyrazine, 6-bromo-3-iodo-;6-Bromo-3-iodoimidazo[1,2-a]pyrazine
Molecular Formula:C6H3BrIN3
Molecular Weight:323.917
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:2.6±0.1 g/cm3
Index of Refraction:1.865
PSA:30.19000
Exact Mass:322.855499
LogP:1.92
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Imidazo[1,2-a]pyrazine, 6-bromo-3-iodo- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Bromo-3-iodoimidazo[1,2-a]pyrazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Bromo-3-iodoimidazo[1,2-a]pyrazine Use and application,6-Bromo-3-iodoimidazo[1,2-a]pyrazine technical grade,usp/ep/jp grade.
Related News: The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774. 6-Bromo-3-iodoimidazo[1,2-a]pyrazine manufacturer The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774. 6-Bromo-3-iodoimidazo[1,2-a]pyrazine supplier Compared to white women, Black women are more likely to be diagnosed with breast cancer before age 50 or with estrogen receptor (ER)-negative and triple-negative breast cancer. 6-Bromo-3-iodoimidazo[1,2-a]pyrazine vendor Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. 6-Bromo-3-iodoimidazo[1,2-a]pyrazine factory Compared to white women, Black women are more likely to be diagnosed with breast cancer before age 50 or with estrogen receptor (ER)-negative and triple-negative breast cancer.